Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC-OPC2: PIPAC for Peritoneal Metastases
NCT03287375Phase 2Completed
- Start
- Dec 2016
- Primary completion
- Feb 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, cisplatin, doxorubicin in Peritoneal metastases. Started Dec 2016; status: completed.
02
Drugs
oxaliplatincisplatindoxorubicin
03
Conditions
Peritoneal metastases
Beyond the preview
Go deeper on NCT03287375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287375.